English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduJaime Merchán, M.D., is the new Translational and Clinical Oncology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Tag: University Of Miami Miller School Of Medicine
Women in Medicine: Dr. Priyamvada Rai to Co-lead Tumor Biology Research Program
Priyamvada Rai, Ph.D., is the new Tumor Biology Research Program co-leader at Sylvester Comprehensive Cancer Center, part of UHealth – University of Miami Health System.
Sylvester Comprehensive Cancer Center Scientists, Collaborators Develop Powerful AI Algorithm to Gain New Insights into Deadly Glioblastoma
(MIAMI, FL, EMBARGOED UNTIL FEB. 2, 2023 AT 11 A.M. EST) — Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with international researchers, have developed a sophisticated AI algorithm that performs advanced…
Digital Reporting Tool Aims to Protect Fire Investigators and Boost Public Safety
After a fire, investigators charged with determining the cause of the blaze sometimes stumble on unstable surfaces, breathe in toxins, or face other health and safety risks. But they had no central place to document their exposure to hazards at work, and researchers had no central place to evaluate that data to try to mitigate those risks — until now.
Neurologist explains autoimmune disease affecting Celine Dion
Dr. Kottil Rammohan, professor of clinical neurology at the Miller School of Medicine, addresses the autoimmune and neurological disorder that is affecting the Canadian singer and that impacts about one or two in a million people.
Meet the 2023 AANEM & ANF President
– The American Association of Neuromuscular &
Electrodiagnostic Medicine (AANEM) and American Neuromuscular Foundation (ANF) are
excited to announce Robert W. Irwin, MD, as the 2023 association and foundation president. Dr.
Irwin has been a dedicated member of AANEM since 2002 and is currently a physical medicine
and rehabilitation (PM&R) physician at University of Miami Miller School of Medicine in
Miami, FL.
Sylvester Comprehensive Cancer Center Receives Approval to Build World-Class Myeloma Research Institute
The Myeloma Research Institute’s launch follows many important accomplishments by C. Ola Landgren, M.D., Ph.D. and his team, who are dedicated to fulfilling a promise of providing the best cancer care to myeloma patients. Florida is among the states with the highest rates of new myeloma diagnoses in the U.S., with 7.9 cases diagnosed in every 100,000 of the state’s residents.
AI and Cancer: Study Highlights Automated System to Calculate Metabolic Tumor Volume
AI-based approach could make it easier to incorporate metabolic tumor volume into clinical trials and possibly patient care
New Optimism on Myelodysplastic Syndromes
Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment approaches for myelodysplastic syndromes (MDS), which are rare and often deadly bone…
Dr. Antonio Iavarone Is Committed to Changing How We Treat Brain Tumors
Antonio Iavarone, M.D., has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more.
Sylvester Plays Pivotal Role in Practice-Changing Anal Cancer Prevention Study Published by NEJM
The New England Journal of Medicine (NEJM) has published the results of a study by Sylvester Comprehensive Cancer Center at the University of Miami Miller School and other investigators on anal cancer prevention in people living with HIV (PLHIV) that will likely establish a…
Sylvester Researchers Study Vaginal Microbiome’s Role in Screening for Endometrial Cancer
The vaginal microbiome differentiates benign disease from endometrial cancer and can even provide insight about the specific endometrial cancer type and disease severity, according to a study by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of…